As of March 2026 Kyverna Therapeutics has a market cap of A$0.74 Billion. This makes Kyverna Therapeutics the world's 7061th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 3rd, 2026 the market cap of Kyverna Therapeutics was reported to be: